What is it about?
Culture conversion at month-2, is globally used as proxy indicator of tuberculosis (TB) chemotherapy efficacy in phase 2 clinical trials.
Featured Image
Why is it important?
This can be used for places from high TB burden and limited resource countries which still do have limited access to liquid culture medium.
Read the Original
This page is a summary of: Predictors of delayed culture conversion among Ugandan patients, BMC Infectious Diseases, April 2017, Springer Science + Business Media,
DOI: 10.1186/s12879-017-2335-7.
You can read the full text:
Contributors
The following have contributed to this page
